Lehrstuhl für Innere Medizin III

Serum Calprotectin Is a Prognostic Marker for Drug-Free Remission in RA (2019) De Moel E, Rech J, Mahler M, Roth J, Schouffoer A, Ronday K, Huizinga T, et al. Conference contribution Identification of Circulating MicroRNA Signatures in Patients with Psoriasis and Psoriatic Arthritis to Develop Novel Strategies for Early Diagnosis of a Bone and Joint Involvement (2019) Haschka J, Simon D, Bayat S, Kleyer A, Kampylafka E, Muschitz C, Skalicky S, et al. Conference contribution BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo (2019) Ross R, Corinaldesi C, Migneco G, El-Sherbiny Y, Holmes S, Distler J, Mckimmie C, Del Galdo F Conference contribution No Difference in Treatment Continuation of Different Biologics in Elderly Patients > 70 Years Compared to Younger Patients <= 65 Years (2019) Strangfeld A, Krueger K, Manger B, Kneitz C, Zink A, Schaefer M Conference contribution Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk (2019) Pachera E, Assass S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution Hsp90 as a Potential Biomarker of Lung and Skin Involvement in Patients with Systemic Sclerosis (2019) Storkanova H, Oreska S, Spiritovic M, Hermankova B, Bubova K, Komarc M, Pavelka K, et al. Conference contribution Individually Tailored Predictions of Flare Probability for Rheumatoid Arthritis Patients on Biologic DMARDs Based on Machine Learning Stacking Meta-Classifier (2019) Vodencarevic A, Simon D, Hartmann F, Reiser M, Hueber A, Tascilar K, Kleyer A, et al. Conference contribution The Urge for Mobile Apps in Rheumatology - a German Patient Perspective (2019) Knitza J, Raab C, Lambrecht A, Simon D, Hagen M, Bayat S, Schett G, et al. Conference contribution The Effect of Nintedanib versus Mycopheolate Mofetil in the FRA2 Mouse Model of Systemic Sclerosis Associated Interstitial Lung Disease (2019) Thuong Trin-Minh , Zhang Y, Distler J, Wollin L Conference contribution Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission (2019) Hagen M, Tascilar K, Reiser M, Haschka J, Kleyer A, Valor L, Manger B, et al. Conference contribution